藏医药对肝胆疾病的认识与治疗  

Understanding and treatment of hepatobiliary diseases in Tibetan medicine

作　　者：刘馨安 潘琳 杨春红 黎世玲 余丽琼 蒲丽丽 刘雅琴 赖先荣[1] LIU Xin-an;PAN Lin;YANG Chunhong;LI Shi-ling;YU Li-qiong;PU Li-li;LIU Ya-qin;LAI Xian-rong(School of Ethnic Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan;School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan)

机构地区：[1]成都中医药大学民族医药学院,四川成都611137 [2]成都中医药大学药学院,四川成都611137

出　　处：《中药与临床》2022年第4期58-64,共7页Pharmacy and Clinics of Chinese Materia Medica

摘　　要：肝胆疾病是一类危害人类生命和健康的疾病,在藏医药体系中属于“赤巴”范畴,根据藏医药的整体观念和肝胆疾病的独特认识,对肝胆疾病的治疗具有丰富而独特的临床经验。本文简要论述了藏医药对肝胆疾病的认识,概述了临床治疗肝胆疾病的常用单味藏药以及藏药复方制剂,以期为肝胆疾病的临床治疗和新药发现提供新思路,进一步发挥藏医药的优势。Hepatobiliary diseases are a type of diseases that endanger human life and health,which belong to the category of"Chiba"in the Tibetan medicine system.According to the overall concept of Tibetan medicine and the unique understanding of hepatobiliary diseases,it has rich and unique clinical experience in the treatment of hepatobiliary diseases.In this article,the understanding of Tibetan medicine on hepatobiliary diseases is briefly discussed,and the common single Tibetan medicines and compound preparations for the clinical treatment of hepatobiliary diseases are summarized,in order to provide new ideas for the clinical treatment and new drug discovery of hepatobiliary diseases,which further exerts the advantages of Tibetan medicine.

关 键 词：藏医药 肝胆疾病 赤巴病 新药发现 

分 类 号：R29[医药卫生—民族医学]